Clinical Trial Update: The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring whether metformin can protect kidney function when combined with cisplatin in muscle-invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• metformin (metformin)

Snippet

Sponsor: Cairo University | Conditions: Muscle-Invasive Bladder Carcinoma | Phase 4 | Status: RECRUITING